Los Angeles—Artificial intelligence (AI)-based drug discovery continues to tout accelerated timelines and novel and effective treatments, yet today’s clinical success…

The BioPharma sector is under constant pressure to bring more novel therapies to market, more quickly and affordably. Attaining this…

Vijay Pande, PhD, founding investor of the Bio + Health fund at Andreessen Horowitz (a16z), and a general partner at…

The buffers used in downstream purification play a critical role in drug manufacturing. However, they can be expensive and difficult…

Despite the powerful cancer-fighting capabilities of treatments based on T cells containing an engineered chimeric antigen receptor (CAR) to fight…

Manufacturing platforms for cell and gene therapies (CGT) are becoming more automated and integrated but, despite recent gains, there’s still…

AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale. The software, created…

The Vilcek Foundation Prizes in Biomedical Science raise awareness of immigrant contributions in the United States and foster appreciation for…

University of Pittsburgh School of Medicine researchers carrying out a small pilot clinical trial demonstrating that a drug-free, minimally invasive…

Researchers at Washington State University (WSU) report that they have created genetically-engineered mice that could help accelerate anti-aging research. “This…